Skip to main content

View full-text article in PMC

. 2014 Dec 16;20(2):104–112. doi: 10.1016/j.rpor.2014.11.008

Table 3.

Planning modification after ¹¹C-choline PET/CT.^a

Patient	PET findings	CTV prior to PET	CTV after PET	Dose prescribed prior to PET	Dose prescribed after PET
1	Positive bone metastases	Prostate plus seminal vesicles	Pelvic lymph nodes, seminal vesicles, prostate, pubic bone	66 Gy^b	70 Gy^c
2	Negative bone metastases	Pelvic lymph nodes, seminal vesicles, prostate, vertebral bone	Prostate plus proximal seminal vesicles	No RT or 70 Gy^c	66 Gy^b
3	Positive lymph nodes	Prostate plus proximal seminal vesicles	Retroperitoneal and pelvis lymph nodes, seminal vesicles, prostate	66 Gy^b	70 Gy^c (64.4 Gy, 2.3 Gy to retroperitoneal positive lymph nodes)
4	Positive lymph nodes	Prostate plus proximal seminal vesicles	Pelvic lymph nodes, seminal vesicles, prostate	66 Gy^b	70 Gy^c
5	Positive tumour bed and lymph nodes	Tumour bed	Pelvic lymph nodes, tumour bed	60 Gy^b	70 Gy^c
6	Positive tumour bed and lymph nodes	Tumour bed	Pelvic lymph nodes, tumour bed	60 Gy	70 Gy^c

^a

PET/CT: positron emission tomography/computed tomography.

^b

3 Gy/fraction.

^c

2.5 Gy/fraction.